influenza
viru
envelop
singlestrand
segment
negativesens
rna
viru
respons
season
epidem
worldwid
world
health
organ
estim
season
influenza
result
five
million
case
sever
ill
death
annual
risk
factor
associ
sever
diseas
well
defin
sever
diseas
often
seen
among
person
age
year
infant
pregnant
women
individu
age
underli
health
condit
interact
viru
host
genet
immun
statu
clearli
play
import
role
determin
outcom
infect
human
anim
model
season
influenza
influenza
viru
avian
influenza
viru
influenza
strain
cytokin
level
host
respiratori
secret
serum
associ
diseas
sever
outcom
hypercytokinemia
observ
human
infect
influenza
viru
found
correl
sever
mortal
innat
immun
respons
human
infect
influenza
viru
suggest
proinflammatori
mediat
contribut
diseas
pathogenesi
elev
blood
level
elev
level
mig
observ
patient
respons
may
contribut
acut
lung
injuri
acut
respiratori
distress
syndrom
ard
multiorgan
failur
observ
mani
patient
recent
interferoninduc
transmembran
protein
shown
import
role
restrict
morbid
mortal
mice
infect
influenza
viru
major
host
respons
studi
influenza
focus
direct
measur
immunolog
marker
blood
patient
express
profil
lung
tissu
anim
model
howev
studi
assess
function
interact
gene
express
profil
individu
clinic
present
perform
prospect
studi
explor
function
interact
link
data
clinic
featur
patient
infect
influenza
virus
variou
degre
sever
provid
insight
pathogenesi
sever
influenza
sampl
moder
sever
influenza
patient
collect
multicent
doubleblind
random
control
trial
standard
dose
mg
bd
pediatr
equival
versu
doubl
dose
mg
bd
pediatr
equival
oseltamivir
treatment
influenza
patient
requir
hospit
regist
clinicaltrialsgov
studi
took
place
across
five
hospit
vietnam
three
hospit
indonesia
four
hospit
thailand
one
singapor
hospit
part
southeast
asia
infecti
diseas
clinic
research
network
seaicrn
primari
endpoint
trial
proport
subject
detect
viral
rna
respiratori
swab
day
measur
rtpcr
wholeblood
sampl
collect
paxgen
tube
day
enrol
studi
studi
avoid
effect
treatment
host
respons
whole
blood
sampl
collect
oseltamivir
treatment
studi
day
follow
day
use
inclus
criteria
studi
age
year
ii
durat
ill
day
iii
posit
result
influenza
viru
b
use
rapid
antigen
test
qualit
revers
transcriptas
polymeras
chain
reaction
rtpcr
respiratori
specimen
iv
presenc
least
one
respiratori
symptom
cough
dyspnea
sore
throat
v
diseas
requir
hospit
admiss
vi
one
follow
sign
sever
influenza
new
infiltr
chest
xray
b
tachypnea
respiratori
rate
age
year
rate
age
year
rate
age
year
rate
age
year
c
dyspnea
unabl
speak
full
sentenc
use
accessori
respiratori
muscl
hypoxia
arteri
oxygen
satur
room
air
transcutan
method
subject
infect
avian
influenza
viru
enrol
degre
sever
exclus
criteria
pregnanc
urin
posit
ii
breast
feed
iii
prior
oseltamivir
therapi
hour
durat
doubl
dose
durat
within
past
day
iv
allergi
sever
intoler
oseltamivir
v
creatinin
clearanc
crcl
mlmin
sever
influenza
defin
requir
mechan
ventil
ii
present
sever
tachypnea
respiratori
rate
age
year
rate
age
year
rate
age
year
rate
age
year
hypoxia
arteri
oxygen
satur
room
air
transcutan
method
eden
studi
conduct
accord
declar
helsinki
approv
nation
health
group
nhg
ethic
review
board
dsrb
individu
elig
inclus
gave
written
consent
particip
studi
year
age
sampl
moder
sever
influenza
patient
collect
multicent
doubleblind
random
control
trial
standard
dose
mg
bd
pediatr
equival
versu
doubl
dose
mg
bd
pediatr
equival
oseltamivir
treatment
influenza
patient
requir
hospit
regist
clinicaltrialsgov
onecolor
array
technolog
illumina
platform
illumina
inc
san
diego
ca
usa
use
gene
express
microarray
brief
wholeblood
ml
paxgen
rna
tube
qiagen
sussex
uk
extract
use
paxgen
rna
kit
qiagen
biotinyl
amplifi
crna
gener
vitro
transcript
ivt
technolog
use
illumina
totalprep
rna
amplif
kit
ambion
inc
austin
tx
usa
accord
manufactur
instruct
purif
crna
hybrid
illumina
beadchip
contain
probe
gene
transcript
hour
follow
manufactur
instruct
illumina
inc
san
diego
ca
usa
follow
wash
block
stain
step
final
chip
scan
illumina
bead
array
reader
confoc
scanner
check
use
illumina
qc
analysi
background
subtract
raw
gene
express
intens
data
export
genomestudio
softwar
use
analysi
dataset
normal
use
r
http
wwwbioconductororg
describ
first
raw
data
transform
z
score
transform
perform
z
score
calcul
sampl
subtract
overal
mean
gene
intens
raw
intens
signal
gene
refer
data
divid
standard
deviat
measur
intens
follow
formula
g
gene
microarray
repres
aggreg
measur
gene
use
z
score
base
valu
identifi
differenti
express
probe
comparison
two
group
sampl
probe
high
z
score
highli
express
low
z
score
least
express
probe
convent
fold
chang
calcul
could
simpl
understand
low
intens
data
much
variabl
fals
posit
rate
could
increas
contrast
high
intens
probe
significantli
express
might
identifi
z
score
transform
calcul
number
standard
deviat
particular
data
point
form
mean
identifi
differenti
express
probe
group
patient
z
ratio
gene
calcul
z
score
calcul
divid
mean
differ
z
score
group
standard
deviat
z
score
differ
across
geneswher
repres
aggreg
measur
gene
z
ratio
equival
signific
level
p
valu
samr
packag
r
wwwbioconductororg
use
zscore
normal
data
comparison
acut
convalesc
sampl
ofi
mild
moder
patient
two
classpair
test
use
comparison
acut
convalesc
sampl
patient
sever
influenza
two
classunpair
test
use
sam
procedur
combin
calcul
ttest
statist
valu
gene
subsequ
permut
n
analysi
calcul
fals
discoveri
rate
fdr
statist
data
z
differ
z
ratio
sam
combin
identifi
differenti
express
gene
signific
gene
sam
fdr
z
ratio
differenti
express
gene
deg
identifi
use
ingenu
pathway
analysi
ipa
wwwingenuitycom
ipa
databas
contain
canon
pathway
function
gene
relationship
expertlycur
literatur
help
us
understand
diseas
process
identifi
key
biolog
function
novel
molecular
network
deg
list
crossreferenc
databas
identifi
enrich
pathway
associ
studi
condit
signific
canon
pathway
defin
fisher
exact
test
p
valu
correct
addit
filter
p
valu
enrich
pathway
analyz
care
take
account
ratio
number
gene
pathway
total
patient
flulik
symptom
recruit
studi
patient
infect
influenza
viru
influenza
pandem
season
viru
rhinoviru
coinfect
rhinoviru
season
viru
pathogenneg
patient
time
interv
therefor
design
ofi
group
amongst
pathogeninfect
patient
infect
rhinoviru
coinfect
rhinoviru
remov
patient
infect
influenza
viru
use
data
analysi
n
patient
defin
mild
influenza
hospit
present
symptom
moder
sever
influenza
match
durat
ill
moder
sever
patient
mild
influenza
sampl
collect
second
time
point
rang
day
day
followup
sampl
week
use
baselin
characterist
patient
summar
tabl
clinic
symptom
summar
tabl
sampl
moder
sever
influenza
patient
collect
time
frame
total
whole
blood
sampl
patient
collect
patient
patient
infect
influenza
viru
patient
viru
three
season
one
viru
among
patient
fulfil
criteria
sever
diseas
remain
patient
consid
moder
diseas
although
sampl
size
small
appear
correl
sever
infect
influenza
viru
strain
baselin
characterist
group
patient
summar
tabl
first
time
point
patient
sever
diseas
enrol
median
durat
ill
day
interquartil
rang
iqr
day
patient
moder
diseas
day
iqr
day
distribut
day
ill
prior
enrol
statist
signific
group
enrol
sever
patient
significantli
higher
total
white
blood
cell
count
tabl
differenti
white
cell
count
scrutin
patient
sever
diseas
significantli
higher
absolut
neutrophil
count
absolut
platelet
count
also
significantli
lower
patient
sever
diseas
comparison
febril
patient
unknown
aetiolog
patient
influenza
infect
show
strong
antivir
cytokin
respons
amongst
signific
pathway
tolllik
receptor
signal
signal
role
pkr
interferon
induct
antivir
respons
nfkb
signal
significantli
upregul
influenza
patient
signific
gene
associ
pathway
condit
summar
figur
although
pathway
activ
influenza
patient
regardless
sever
differ
gene
set
pathway
activ
patient
differ
outcom
figur
exampl
patient
sever
influenza
signific
upregul
nfkbia
whilepati
moder
influenza
share
similar
antivir
cytokin
respons
sever
mild
outcom
tnfaip
gene
signal
signal
product
nitric
oxid
reactiv
oxygen
speci
macrophag
mapk
signal
upregul
moder
sever
patient
tabl
comparison
patient
sever
outcom
moder
mild
outcom
character
signific
upregul
protein
ubiquitin
interferon
signal
pathway
activ
irf
cytosol
pattern
recognit
receptor
tabl
interferon
signal
pathway
complet
attenu
patient
sever
influenza
one
gene
activ
wherea
pathway
strongli
upregul
patient
moder
p
ratio
gene
mild
p
ratio
gene
outcom
figur
similarli
protein
ubiquitin
pathway
highli
upregul
moder
p
ratio
gene
mild
p
ratio
gene
patient
upregul
sever
outcom
tabl
mani
interferoninduc
transmembran
ifitm
protein
shown
play
import
role
influenza
diseas
outcom
investig
ifitm
interferoninduc
gene
total
includ
illumina
beadchip
tabl
show
ifitm
interferonrel
gene
express
level
patient
group
amongst
transcript
transcript
significantli
upregul
patient
moder
mild
outcom
none
signific
patient
sever
outcom
ofi
tabl
amongst
signific
gene
oasl
rigi
highli
upregul
moder
mild
patient
downregul
patient
sever
outcom
tabl
cell
nk
cell
relat
respons
downregul
group
influenza
patient
weaker
magnitud
ofi
tabl
natur
killer
cell
signal
crosstalk
dendrit
cell
natur
killer
cell
signal
helper
cell
signal
lymphocyt
amongst
signific
pathway
similar
upregul
pathway
although
pathway
name
share
differ
group
gene
activ
pathway
differ
nk
cell
respons
relat
gene
downregul
moder
sever
patient
gene
downregul
three
group
influenza
patient
figur
hladmb
vegfa
downregul
patient
sever
outcom
figur
besid
nk
cell
cell
relat
respons
pathway
relat
host
translat
regul
signal
signal
mtor
signal
significantli
downregul
influenza
infect
group
stronger
magnitud
patient
mild
moder
diseas
investig
transcript
profil
patient
wide
rang
diseas
sever
noninfluenza
fever
unknown
aetiolog
mild
moder
sever
influenza
found
patient
confirm
influenza
infect
similar
stronger
host
respons
comparison
patient
fever
unknown
aetiolog
interferon
respons
shown
strongli
upregul
influenza
viru
infect
howev
exact
mechan
interferon
respons
differ
clinic
sever
influenza
describ
found
interferon
signal
pathway
protein
ubiquitin
pathway
attenu
patient
fever
unknown
aetiolog
patient
sever
influenza
manifest
suggest
protect
role
pathway
diseas
mechan
furthermor
data
suggest
interferon
signal
pathway
interferoninduc
transmembran
protein
ifitm
play
import
protect
role
diseas
mechan
amongst
ifitm
shown
block
influenza
viru
entri
cell
limit
sever
influenza
viru
infect
mice
data
suggest
ifitm
isg
gene
could
similarli
play
import
role
diseas
outcom
apart
interferon
pathway
ubiquitini
signal
pathway
also
attenu
patient
sever
outcom
protein
ubiquitin
posttransl
process
involv
addit
ubiquitin
protein
substrat
play
import
role
proteinprotein
interact
exampl
protein
influenza
viru
could
inhibit
ifn
respons
inhibit
ubiquitin
viral
rna
sensor
rigi
rigi
key
host
sensor
viral
rna
insid
cytoplasm
account
induct
host
ifn
respons
ubiquitin
card
domain
rigi
essenti
activ
nfkb
turn
induc
ifn
product
mention
ubiquitin
rigi
key
process
host
could
recogn
influenza
viru
rna
induc
interferon
respons
attenu
protein
ubiquitin
pathway
rigi
could
lead
lack
interferon
respons
sever
patient
also
shown
host
protein
ubiquitin
system
requir
influenza
viru
replic
may
explain
percentag
patient
viru
detect
sampl
collect
lower
sever
group
comparison
moder
group
mention
although
pathway
upregul
patient
differ
sever
outcom
certain
gene
nfkbia
upregul
sever
patient
shown
mous
model
capabl
digest
extracellular
matrix
produc
mainli
neutrophil
requir
neutrophil
migrat
respiratori
tract
respons
viral
replic
upregul
sever
patient
suggest
contribut
gene
diseas
outcom
upregul
suppressor
cytokin
signal
gene
neg
regulatori
function
innat
immun
respons
could
inhibit
type
interferon
signal
lack
interferon
signal
sever
patient
could
explain
upregul
patient
recent
shown
play
role
innat
immun
respons
influenza
infect
express
stronger
infect
highli
pathogen
influenza
viru
amongst
downregul
pathway
cell
signal
respons
nk
cell
respons
predomin
influenza
patient
interestingli
pathway
patient
sever
diseas
predomin
comparison
patient
mild
moder
diseas
previou
studi
shown
type
interferon
respons
could
exploit
opportunist
pathogen
influenza
infect
turn
could
increas
host
suscept
secondari
bacteri
infect
streptococcu
pneumonia
neg
regul
cell
respons
detect
secondari
bacteri
infect
moder
sever
patient
use
convent
blood
cultur
rrna
sequenc
data
shown
could
due
fact
patient
treat
antibiot
recruit
studi
mani
gene
involv
cell
nk
cell
respons
downregul
influenza
infect
patient
regardless
clinic
outcom
howev
found
key
transcript
cell
nk
cell
signal
respons
downregul
patient
sever
influenza
suggest
import
role
transcript
sever
influenza
previou
studi
shown
sever
influenza
diseas
associ
transient
nk
cell
cell
respons
amongst
downregul
gene
report
show
direct
interact
influenza
virus
wherebi
viru
downregul
cytotox
nk
cell
mediat
gene
addit
singl
polymorph
shown
strongli
associ
decreas
lung
function
recent
conduct
larg
scale
n
genomewid
associ
studi
forc
expiratori
volum
surrog
lung
function
despit
rel
larg
sampl
size
moder
mild
ofi
group
one
limit
studi
small
sampl
size
sever
influenza
patient
manag
recruit
durat
studi
nevertheless
gener
larg
exploratori
transcriptom
dataset
influenza
diseas
wide
spectrum
sever
although
valid
find
beyond
scale
current
studi
dataset
serv
valuabl
data
mine
research
field
select
gene
candid
hypothesi
test
valid
taken
togeth
investig
global
host
transcript
profil
influenza
viru
infect
patient
differ
clinic
outcom
provid
insight
global
gene
express
influenza
viru
infect
particular
reveal
attenu
interferon
protein
ubiquitin
pathway
downregul
nk
cell
relat
respons
patient
sever
influenza
viru
infect
lastli
propos
follow
candid
gene
studi
ifitm
rigi
